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Synthetic protein-DNA conjugates are valuable tools with applications in fields including nanobiotechnology, bioanalytical
chemistry, and molecular diagnostics, and various synthetic methods for their production have been developed during the
past three decades.The present article reviews current methodologies for the synthesis of covalent protein-DNA conjugates
with particular focus on the regiospecificity and stoichiometry of these reactions.
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Introduction
Synthetic DNA-protein conjugates generated either by cova-
lent or non-covalent coupling chemistry have recently attracted
attention as tools for nanobiotechnology, bioanalytical chem-
istry, and molecular diagnostics. Their potential applications
as biosensors, artificial nucleases, and in the design of pro-
tein microarrays through DNA-directed immobilization have
recently been reviewed.[1] Moreover, double-stranded DNA has
numerous attractive features for the bottom-up design of diverse
supramolecular building blocks for the production of nano-
structures, i.e. its rigidity, predictable structure, and assembly
through complementary hybridization. Examples of nanostruc-
tures include cubes,[2] tetrahedra,[3] octahedra,[4–6] and 2D
arrays,[6–9] with the most impressive being the scaffolded DNA
origamis.[10]
The introduction of proteins into DNA nanostructures can
afford new functions and functional groups at their surfaces. The
inherent properties of proteins, e.g. recognition elements and cat-
alytic activities, can be exploited by their introduction at defined
positions. A major current area of application of protein-DNA
conjugates recently reviewed by Niemeyer[1] is in the produc-
tion of DNA-labelled antibodies for immunodiagnostics. Such
devices offer ways to increase the sensitivity of immunoassays by
several orders of magnitude using the power of polymerase chain
reaction (PCR) as a means for detection.[11] Protein-DNA con-
jugates have also been used in proximity ligation assays,[12–14] in
immuno-PCR detection methods,[15–17] to organize biocatalysts
in series for sequential reactions to study proximity effects,[18,19]
and for the reassembly of a split luciferase directed through DNA
hybridization.[20] While these conjugates are useful at present,
they will be amenable to many additional applications once their
synthesis is made more routine.
Covalently linked protein-DNA conjugates are of particu-
lar interest as they do not dissociate over time when diluted
or faced with inappropriate buffer or temperature conditions.
Covalent coupling is a condicio sine qua non for multiplex
applications (e.g. simultaneous detection of multiple analytes
using different protein-DNA conjugates). Methods for cova-
lent attachment of proteins to nucleic acids include chemical
cross-linking of oligonucleotides to protein lysine or cysteine
residues,[21–23] expressed protein-ligation,[16,24] chemoenzy-
matic methods,[25–28] and the use of photoaptamers.[29] Although
outside the scope of this review, it is worth mentioning that
the great majority of non-covalent protein-DNA conjugates still
exploit the streptavidin-biotin interaction (KD = 10−15 M),[1]
with streptavidin as a protein connector between a biotinylated
DNA and a biotinylated protein; the non-covalent protein-
DNA conjugates typically have variable stoichiometry because
streptavidin is a tetramer.
Our objective here is to review the current state of methods
for the synthesis of covalently linked protein-DNA conjugates
with particular focus given to the regiospecificity and stoichio-
metry of the reactions. Limitations of methods and applications
of the conjugates are also discussed. We will not discuss the
synthesis of peptide oligonucleotide conjugates, as they have
recently been thoroughly reviewed,[30] nor will we focus much
on classic methods based on commercially available bifunctional
cross-linkers.
Using the Protein’s Functional Groups
A little more than 20 years ago, Corey and Schultz reported
the synthesis of a conjugate consisting of a nuclease covalently
attached to a single-stranded DNA moiety, which enabled it to
hybridize to a complementary sequence located in a plasmid
to form a triple helix, then to specifically cleave this site.[21]
Staphylococcal nuclease was covalently attached to a 3′-thiol
containing oligonucleotide through a disulfide link to a unique
cysteine that had been engineered in the enzyme.[21,31] Cysteine
is a relatively rare amino acid and thiol chemistry offers simple
ways to site-specifically attach oligonucleotides. Unfortunately,
mutagenesis and knowledge about the structure of the protein
is prerequisite. Gianneschi and co-workers recently used the
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Fig. 1. Homogeneous covalent protein-DNA conjugates. Green lozenges represent the protein moieties.
same strategy for the design of a programmable DNA-regulated
semisynthetic enzyme.[32]
Proteins also offer exposed lysine residues containing reac-
tive amines that can be used for cross-linking with commer-
cial bifunctional reagents to generate protein-DNA conjugates.
These methods are acceptable so long as they do not functionally
inactivate the protein.As many lysine residues are present at pro-
tein surfaces, DNA labelling is often a random process that leads
to heterogeneous conjugates with variable stoichiometry and
regiospecificity.[14] These methods have nevertheless been suc-
cessfully applied to the production of antibody-DNA conjugates
for use in ultrasensitive diagnostics including immuno-PCR.[17]
Intein-Based Strategies for the Production
of Homogeneous Conjugates
In contrast, protein-DNA conjugates with well characterized sto-
ichiometry and regiospecificity are required for the bottom-up
design of supramolecular architectures, and recent advances
have focussed particularly on synthetic methods for their gen-
eration. One example of such regiospecific conjugation took
advantage of a technique called expressed protein ligation origi-
nally developed for the semi-synthesis of proteins.[33] The target
protein was genetically fused to an intein with protein splicing
activity, followed by a chitin-binding domain.[34] The protein
was bound on a column to a chitin matrix, then liberated from
it by reaction with mercaptoethansulfonic acid, generating a C-
terminal thioester through which the target protein was ligated to
a cysteine-PNA conjugate. These conjugates were successfully
used for the production of a protein chip through DNA-directed
immobilization. Later the same group reported the production
of the protein-DNA conjugate (1) in Fig. 1,[35] and Burbulis and
coworkers have produced protein-DNA ‘tadpoles’ using a sim-
ilar approach.[16] Until recently, expressed protein ligation was
restricted to labelling of the C-terminus of a protein, but Takeda
and coworkers have developed a novel intein-based method for
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Fig. 2. Mechanistic aspects of protein-DNA conjugation. (a) Sortase mediated ligation. (b) Putative photocross-linking mechanism of the Tus-Ter variant
complex.
the labelling of the N-terminus via native chemical ligation to
afford the protein-DNA conjugate (2).[36]
Chemoenzymatic Methodologies for the Production
of Homogeneous Conjugates
Puromycin is a fungal secondary metabolite that inhibits pro-
tein translation on ribosomes by mimicking an aminoacylated
tRNA. This results in translation abortion through covalent
bond formation between puromycin and the C-terminal amino
acid of a growing peptide chain. About 10 years ago, Roberts
and Szostak[37] used this property to link proteins to mRNAs
for in vitro evolution experiments. Inspired by this pioneer-
ing work, Humenik and coworkers recently described the
ribosome-mediated C-terminal labelling of an esterase by a
2′-deoxycytidylyl-(3′-5′)-puromycin analogue bearing an azide
group. The azide modified esterase was then reacted with
a 5′-alkyne modified oligonucleotide by CuI-catalyzed [3+2]
cycloaddition (click) chemistry to yield the protein-DNA conju-
gate (3).[27] Also, the recent development of a method for the
production of internally alkyne modified oligonucleotides[38]
could be very useful as it would offer a way to free both 5′
and 3′ ends of an oligonucleotide in a conjugate.
A chemoenzymatic approach recently developed by
Duckworth and coworkers[26] produced various protein-
oligonucleotide conjugates (4) that can spontaneously assemble
into defined nanoarchitectures by cDNA hybridization. The
enzyme, protein farnesyltransferase, was used to label an engi-
neered substrate protein containing a C-terminal tetrapeptide
(SVIA) tag with an azide-modified isoprenoid diphosphate,
and site specific DNA conjugation was achieved by a click
reaction of the protein azide with a 5′-alkyne-modified DNA.
This strategy yielded a short and compact protein-DNA linkage
that allowed precise control over protein spacing and orien-
tation in the assembled nanostructure. Also of relevance to
the use of click chemistry is a recent report of the in vivo
site specific incorporation of an alkyne moiety into calmod-
ulin using a pyrrolysine analogue.[39] This technique could
potentially be useful for the synthesis of protein-DNA conju-
gates as azide-labelled oligonucleotides are now commercially
available.
Another enzymatic method described in 2007 uses the com-
mercially available SNAP-Tag system for the covalent linkage
of proteins with their encoding DNA sequences for in vitro
protein evolution;[28] an O6-benzylguanine moiety incorporated
into DNA in a PCR primer serves as a substrate for a fusion
protein containing a mutant form of O6-alkylguanine-DNA
alkyltransferase, thus establishing a covalent link to the DNA.
In Staphyloccocus aureus, a transpeptidase called sortase,
site-specifically attaches proteins to the surface of the bacterium.
It did not take long after the discovery of sortase for development
of sortase-based methods for the synthesis of protein fusions and
labelling of proteins with chemical probes to transpire. Recently,
Pritz and coworkers[25] used sortase to ligate a synthetic peptide-
PNA conjugate containing the sortase LPXTG recognition motif
with the N-terminal GGG substrate motif of a synthetic peptide
(Fig. 2a). Although the production of a genuine protein-DNA
conjugate by this approach has apparently not been described,
sortase is obviously a great tool to use to make one.
Photochemical Methods
Photocross-linking reactions have been used for decades to
locate protein-binding sites in nucleic acids for transcription fac-
tors, ribosomal and replicative proteins, and to map amino acids
in proteins at nucleic acid interaction sites. Photo-activation of
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the aromatic nucleobases can lead to covalent bonds with nearby
electron rich amino acid side chains in a bound protein. Cross-
linking yields are usually low, but can be improved by use of
the more photo-reactive 5-bromodeoxyuridine (BrdU) in place
of thymidine in the DNA molecules.
In one approach to exploitation of photocross-linking, single-
stranded nucleic acid photo-aptamers that bind proteins with
high affinity have been selected by SELEX for the production
of protein microarrays.[29] Unlike the earlier examples of meth-
ods specifically designed to produce homogenous protein-DNA
conjugates as soluble reagents, photo-aptamers were selected to
bind and covalently capture proteins at a surface to increase
the sensitivity of aptamer-based microarrays. Some of these
photo-aptamers can be cross-linked to their target proteins with
yields that approach 80%.[40] However, there has been no report
yet of their use for the large-scale synthesis of protein-DNA
conjugates.
We have recently investigated photo-conjugation methods
that take advantage of the strong site-specific interaction of
the Tus replication terminator protein with its 23-bp recogni-
tion sequence, Ter.[41] A Ter DNA oligonucleotide bearing a
single BrdU substitution at a site predicted from X-ray crys-
tal structures[42,43] to bring it close to the aromatic ring of a
phenylalanine residue (F140) in the DNA binding site of Tus,
was used for the large scale synthesis of protein-DNA con-
jugates. Tus and Ter associate easily and rapidly, and at low
salt concentrations the complex dissociates with a half-life of
many hours. When the complexes were UV-irradiated at 312 nm,
up to 65% could be covalently cross-linked within minutes
under mild conditions.[44] A Tus-GFP fusion protein was also
efficiently DNA-labelled using the same method; such a Tus
fusion-based method thus offers promise for the easy preparation
of protein-DNA conjugates that are well defined with respect to
1:1 stoichiometry and regiospecificity. A putative cross-linking
mechanism involving F140 of Tus and the BrdU-substituted Ter
variant is shown in Fig. 2b.
Conclusion
As our knowledge of the structures and properties of
biomolecules expands, so does our desire to manipulate them.
Recent years have seen strong interest in the development of
highly specific protein-DNA conjugation methods for various
applications. This interest is stimulated, for example, by the
desire of nanoscientists to manipulate or design new molec-
ular materials and tools from bottom-up or by self-assembly
processes. Without doubt, we will see further increase in novel
applications especially in the multidisciplinary field of nano-
technology. Many of these conjugates are already employed in
frontier technologies and it is anticipated that many more unan-
ticipated uses of them will come to light in the near future. This
will be facilitated by the improved spatial control offered by
recently described methodologies.
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